Stock Radar: This pharma stock gives a breakout from downward sloping trendline; check target & stop loss
Divi's Laboratories stock has broken out of a downward trendline, signalling a potential upward movement. Experts suggest medium-term traders can buy the stock with a target above 7,000 levels in the next 3-4 months. The stock has shown strong price action, trading above key moving averages and experiencing higher volume during the breakout.
What's Your Reaction?











